Skip to main content
Market intelligence
RAPPHealthcare

Rapport Therapeutics Inc. insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 19, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 19, 2026Krishnaswamy YeleswaramChief Development OfficerSale404$49.90$20,160
Aug 11, 2026Abraham CeesayChief Executive OfficerSale51,499$47.25$2,433,178
Jul 27, 2026Abraham CeesayChief Executive OfficerSale2,210$42.11$93,061